Risk-Benefit Assessment in EUA Granting – pharmaceutical regulatory Risk-Benefit Assessment in EUA Granting: A Step-by-Step Tutorial Guide The Emergency Use Authorization (EUA) is a critical regulatory mechanism that allows for the swift deployment of medical products during public health emergencies. The assessment of risk and benefit is pivotal in the process of granting an EUA, as it determines whether the product’s availability can save lives despite inherent uncertainties. This guide aims to provide pharmaceutical regulatory professionals with a comprehensive overview of the steps involved in conducting a risk-benefit assessment for EUAs, including dossier structure, necessary data, evaluation timelines, and regulatory…

Regulatory Challenges Faced During COVID-19 EUA Submissions – pharmaceutical regulatory Regulatory Challenges Faced During COVID-19 EUA Submissions Step 1: Understanding the Emergency Use Authorization (EUA) The Emergency Use Authorization (EUA) is a mechanism that allows the FDA and similar global bodies to facilitate the availability and use of medical countermeasures, including vaccines and therapeutics, during public health emergencies like the COVID-19 pandemic. For pharmaceutical companies, understanding the specific requirements and processes inherent to the EUA is fundamental. The key regulatory challenge is that the EUA is not a full approval; it is a temporary measure. Hence, understanding how an EUA…

How to Transition from EUA to Full Approval – pharmaceutical regulator How to Transition from EUA to Full Approval – Pharmaceutical Regulator The transition from Emergency Use Authorization (EUA) to full approval is a critical phase for pharmaceutical products, especially in the context of public health emergencies. This full approval signifies that a product has met all regulatory standards, ensuring its safety, efficacy, and quality. This comprehensive guide outlines a step-by-step process for regulatory affairs professionals, clinical medical writers, and other stakeholders involved in this crucial transition. Step 1: Understand the Regulatory Framework for Full Approval Before commencing the transition…

Use of Rolling Review for EUA Applications – pharmaceutical regulatory Use of Rolling Review for EUA Applications under Emergency Use Authorization (EUA) The landscape of pharmaceutical regulatory frameworks has evolved significantly, especially in the context of Emergency Use Authorization (EUA). The Rolling Review process allows for a dynamic approach to regulatory submissions, which can accelerate the availability of critical medical products during public health emergencies. This guide will walk you through the various stages of utilizing the Rolling Review for EUA applications, detailing essential actions and documentation expectations for regulatory professionals in the pharmaceutical sector. Understanding Rolling Review: A Regulatory…

Preparing for EUA Pre-Submission Meetings – pharmaceutical regulatory Preparing for EUA Pre-Submission Meetings: A Comprehensive Guide for Regulatory Affairs Professionals Emergency Use Authorization (EUA) allows for the rapid availability of medical products, particularly during public health emergencies. This tutorial is designed to guide pharmaceutical regulatory professionals through the essential steps necessary to prepare for pre-submission meetings regarding EUA requests. The insights provided will ensure that applicants are well-informed on dossier preparation, data requirements, timelines, and regulatory expectations. Step 1: Understanding the EUA Process and Regulatory Framework The first step in preparing for an EUA pre-submission meeting is to comprehensively understand…